Ultrasound-assisted catheter-directed thrombolysis versus anticoagulation alone for management of submassive pulmonary embolism.

[1]  S. Khan,et al.  Time Trends in Pulmonary Embolism Mortality Rates in the United States, 1999 to 2018 , 2020, Journal of the American Heart Association.

[2]  N. Hara,et al.  Gender Differences Among Patients With Acute Pulmonary Embolism. , 2018, The American journal of cardiology.

[3]  G. Criner,et al.  Submassive Pulmonary Embolism , 2018, American journal of respiratory and critical care medicine.

[4]  M. S. Mcmurtry,et al.  Short- and long-term mortality after pulmonary embolism in patients with and without cancer , 2018, Vascular medicine.

[5]  Michael J. Singh,et al.  Improved early right ventricular function recovery but increased complications with catheter-directed interventions compared with anticoagulation alone for submassive pulmonary embolism. , 2016, Journal of vascular surgery. Venous and lymphatic disorders.

[6]  M. D. de Gregorio,et al.  Pulmonary Embolism Response to Fragmentation, Embolectomy, and Catheter Thrombolysis (PERFECT): Initial Results From a Prospective Multicenter Registry. , 2015, Chest.

[7]  Simon Gibbs,et al.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension , 2015, European Respiratory Journal.

[8]  S. Goldhaber,et al.  A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study. , 2015, JACC. Cardiovascular interventions.

[9]  M. Madani,et al.  Update on chronic thromboembolic pulmonary hypertension. , 2014, Circulation.

[10]  Ralf-Thorsten Hoffmann,et al.  Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism , 2014, Circulation.

[11]  S. Solomon,et al.  GUIDELINES AND STANDARDS , 2010 .

[12]  A. Linhart,et al.  Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. , 2013, Experimental and clinical cardiology.

[13]  Marco Valgimigli,et al.  Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium , 2011, Circulation.

[14]  Yingying Tang,et al.  Ethnic Differences in Out-of-Hospital Fatal Pulmonary Embolism , 2011, Circulation.

[15]  S. Goldhaber,et al.  Chronic thromboembolic pulmonary hypertension. , 2011, The New England journal of medicine.

[16]  B. Kasiske,et al.  Kidney Disease: Improving Global Outcomes , 2009, Nature Reviews Nephrology.

[17]  C. Greyson,et al.  Pathophysiology of right ventricular failure , 2008, Critical care medicine.

[18]  J. Bronzwaer,et al.  Right coronary artery flow impairment in patients with pulmonary hypertension. , 2007, European heart journal.

[19]  M. Fine,et al.  Racial differences in 30-day mortality for pulmonary embolism. , 2006, American journal of public health.

[20]  W. Ageno,et al.  Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. , 2006, Chest.

[21]  J. Heit.  The Epidemiology of Venous Thromboembolism in the Community: Implications for Prevention and Management , 2006, Journal of Thrombosis and Thrombolysis.

[22]  Roslyn A Stone,et al.  Derivation and validation of a prognostic model for pulmonary embolism. , 2005, American journal of respiratory and critical care medicine.

[23]  Paolo Prandoni,et al.  Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. , 2004, The New England journal of medicine.

[24]  A. Rimm,et al.  Race and sex differences in long-term survival rates for elderly patients with pulmonary embolism. , 1998, American journal of public health.

[25]  J. Widimský,et al.  Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. , 1982, Chest.